What does Oxbridge Re Holdings do?
Oxbridge Re Holdings Limited is a Cayman Islands-based specialty property-and-casualty reinsurance holding company whose ordinary shares trade on the Nasdaq Capital Market under the ticker OXBR. Its traditional operating core is narrow: it writes fully collateralized reinsurance contracts for insurers exposed mainly to catastrophe risk in the U.S. Gulf Coast, with particular emphasis on Florida. The company describes its target risks as medium-frequency, high-severity exposures for which it believes historical data can support a disciplined risk-and-return assessment. Its latest business description is available in the 2025 Form 10-K.
Why is this more than a conventional micro-cap reinsurer?
The differentiating strategic project is SurancePlus, which develops tokenized securities representing fractional interests in participating notes linked to reinsurance contracts. Oxbridge’s first product, DeltaCat Re, was followed by EpsilonCat Re, ZetaCat Re and EtaCat Re offerings, and the company has announced T42:2027 and T20:2027 products to be issued on the Solana blockchain. This creates a hybrid model: catastrophe underwriting produces the underlying risk exposure, while tokenization seeks to broaden the pool of outside capital that can fund collateral.
Premiums are earned over treaty periods, while underwriting results depend on catastrophe losses, acquisition costs and the expense base.
Oxbridge Re NS issues participating notes to third parties and uses proceeds to collateralize affiliated reinsurance obligations.
SurancePlus packages fractional interests in reinsurance-linked instruments and is intended to support broader Web3 and RWA offerings.
How does Oxbridge Re make money?
The company’s economics begin with assumed reinsurance premiums. Premium is generally recognized as net premiums earned over the contract term, while claims from covered storms can create sudden, concentrated losses. Investment and other income supplements underwriting revenue, but the asset base is small, so it cannot absorb the fixed public-company and development costs that a large reinsurer could spread over a much bigger premium base.
Which revenue source matters most?
FY2025 net premiums earned were $2.287 million, compared with $2.303 million in FY2024. Total FY2025 revenue was $2.577 million because investment income and smaller gains more than offset unrealized losses. SurancePlus fee income, however, fell to only $1,000 in FY2025 from $312,000 in FY2024. That gap shows why the tokenization strategy should be evaluated as an early-stage capital and product platform rather than as a mature fee engine.
What did the latest quarter show?
The quarter ended March 31, 2026 showed a return to a small profit after the hurricane-driven loss year, but the improvement was not the same as strong underwriting economics. Total revenue declined 10.0% to $623,000 from $692,000, while net premiums earned declined 6.7% to $555,000. The company reported $22,000 of net income attributable to ordinary shareholders, compared with a $139,000 loss in the prior-year quarter. The detailed filing is the March 31, 2026 Form 10-Q, and the accompanying first-quarter earnings release summarizes the operating ratios.
Why did profit improve despite lower revenue?
| Metric | Q1 2026 | Q1 2025 | Interpretation |
|---|---|---|---|
| Total revenue | $623K | $692K | Lower premiums and investment income reduced the top line. |
| Total expenses | $583K | $570K | Professional, investor-relations and Web3 costs kept the expense base elevated. |
| Tokenholder attribution | $2K expense | $247K expense | The much smaller allocation to tokenholders was a major swing factor. |
| Ordinary shareholder result | $22K income | $139K loss | The quarter crossed slightly above break-even, but at a near-100% expense ratio. |
How did strategic turning points shape today’s model?
Oxbridge’s history is best understood as a sequence of attempts to solve a small reinsurer’s central constraint: access to risk capital without permanently issuing excessive common equity. The traditional vehicle supplies underwriting expertise; the sidecar and token offerings seek to add third-party collateral and diversify funding.
-
2013Oxbridge Re Holdings and Oxbridge Reinsurance were formed in the Cayman Islands, establishing the regulated platform for fully collateralized catastrophe reinsurance.
-
2014The company became public, giving it a listed equity currency but also adding recurring SEC, audit and governance costs.
-
2020Oxbridge Re NS issued participating notes, proving a sidecar structure could bring outside capital into affiliated reinsurance programs.
-
2022SurancePlus was incorporated to tokenize reinsurance-linked interests and broaden the company beyond conventional private note placements.
-
2023DeltaCat Re raised $2.448 million, including about $1.280 million from third parties and $1.167 million from Oxbridge.
-
2024EpsilonCat Re raised $2.878 million, including about $1.469 million from third parties and $1.409 million from Oxbridge.
-
2025-2026ZetaCat, EtaCat, T42:2027 and T20:2027 extended the product sequence, while Hurricane Milton losses tested whether outside capital truly cushions ordinary shareholders.
What did the Hurricane Milton experience prove?
In FY2025, two contracts experienced adverse loss development linked to Hurricane Milton: one full-limit loss of $2.3 million and a second partial loss of $442,000. The company recorded $2.742 million of losses and loss-adjustment expenses, yet stated that the net impact on Oxbridge equity was $1.43 million after the portion borne by external tokenholders. This is the strategic proof point for the capital-sharing model: third-party participation can reduce, but not eliminate, the volatility borne by ordinary shareholders.
How financially strong is Oxbridge Re?
At March 31, 2026, total assets were $8.737 million and total shareholders’ equity was $6.095 million. Cash and restricted cash totaled $8.188 million, but $7.303 million was restricted, primarily because collateral must remain in trust for cedants. That distinction is critical: restricted cash supports underwriting promises but is not equivalent to unrestricted liquidity available for corporate spending.
What does the annual baseline say about cash generation?
| Financial line | FY2025 | FY2024 | Why it matters |
|---|---|---|---|
| Total revenue | $2.577M | $0.546M | The increase mainly reflects less severe unrealized investment losses, not premium growth. |
| Net loss to ordinary shareholders | $(2.079)M | $(2.726)M | Losses persisted despite reported revenue improvement. |
| Operating cash flow | $(1.348)M | $(0.284)M | Corporate and development costs consumed liquidity. |
| Shareholders’ equity | $5.975M | $4.110M | Equity rose partly because new shares were issued, not because the business generated retained earnings. |
Does regulatory capital provide a safety margin?
Both reinsurance subsidiaries were above their Cayman Islands Monetary Authority minimum and prescribed capital requirement of $500,000 at March 31, 2026. Oxbridge Reinsurance had net worth of $56,000 as presented in the filing’s stated units, while Oxbridge Re NS had net worth of $631,000; the company said each exceeded its applicable requirement under the approved business plan. Because the filing expresses many balances in thousands, researchers should read the regulatory note carefully rather than compare the figures casually with consolidated equity.
Which insurance KPIs matter most?
For a reinsurer, revenue growth alone can be misleading. A contract can generate attractive premium for several quarters and then produce a single severe loss that reverses years of underwriting profit. Oxbridge therefore emphasizes loss ratio, acquisition-cost ratio, expense ratio and combined ratio.
| KPI | Formula | Latest reading | Interpretation |
|---|---|---|---|
| Loss ratio | Losses and LAE / net premiums earned | 0.0%, Q1 2026 | No catastrophe losses were recognized in the quarter. |
| Acquisition ratio | Acquisition costs / net premiums earned | 11.0%, Q1 2026 | Treaty placement costs remained stable. |
| Expense ratio | Acquisition and G&A costs / net premiums earned | 105.0%, Q1 2026 | The small premium base could not absorb corporate and Web3 expenses. |
| Combined ratio | Loss ratio + expense ratio | 105.0%, Q1 2026 | Even with no losses, the expense burden prevented an underwriting profit. |
What gives Oxbridge Re a competitive advantage?
Oxbridge does not have the scale, diversification or ratings breadth of global reinsurers. Its potential advantage is specialization: a narrow Gulf Coast focus, fully collateralized structures and a willingness to use sidecar and tokenized capital. These features can make it useful to regional insurers that need catastrophe capacity but do not necessarily require a large multiline counterparty.
Where could the tokenization model be defensible?
| Capability | Potential advantage | Constraint |
|---|---|---|
| Licensed underwriting platform | Links digital instruments to actual reinsurance contracts. | Regulatory, legal and disclosure complexity remains high. |
| Sidecar experience | Provides an established mechanism for external risk capital. | The company remains responsible for sourcing and structuring attractive treaties. |
| Public-company transparency | SEC reporting may improve visibility compared with private sponsors. | Public-company costs are heavy relative to revenue. |
| Repeat token series | Creates operational learning and a potential distribution track record. | Fee income has not yet demonstrated stable scale. |
Who are the main competitors?
In traditional catastrophe reinsurance, Oxbridge competes indirectly with large global reinsurers, Bermuda-based specialty carriers, insurance-linked securities funds and private collateralized reinsurers. In tokenized real-world assets, it also competes for investor attention with conventional catastrophe bonds, private reinsurance sidecars and other digital-security platforms. The company’s niche may reduce direct head-to-head competition, but it also limits diversification and bargaining power.
Who owns Oxbridge Re stock, and why does governance matter?
Oxbridge has one ordinary share class with one-share-one-vote economics, but ownership is relatively concentrated for a micro-cap company. The latest available detailed proxy ownership table before the 2026 annual-report amendment was measured at July 25, 2025. It showed Allan Martin at 11.75%, Chairman and CEO Jay Madhu at 11.72%, CFO Wrendon Timothy at 3.37%, and all five directors and executive officers together at 16.47%. The official source is the 2025 definitive proxy statement.
| Holder or group | Beneficial shares | Ownership | Source date |
|---|---|---|---|
| Allan Martin | 949,422 | 11.75% | July 25, 2025 |
| Jay Madhu | 933,678 | 11.72% | July 25, 2025 |
| Wrendon Timothy | 257,530 | 3.37% | July 25, 2025 |
| Directors and executives as a group | 1,328,444 | 16.47% | July 25, 2025 |
How do dilution and incentives affect the ownership story?
The share count has risen materially. Ordinary shares outstanding increased from 6.379 million at December 31, 2024 to 7.664 million at December 31, 2025, 7.801 million at March 31, 2026 and 8.101 million by May 11, 2026. FY2025 at-the-market sales raised gross proceeds of about $901,000 at an average price of $3.13 per share. At March 31, 2026, 451,250 options and 1.412 million warrants were anti-dilutive for accounting purposes, but they still represent potential future dilution if market prices and exercise economics change.
Management incentives also have direct equity effects. The company granted 137,252 restricted shares during Q1 2026 at a weighted-average grant-date fair value of $1.31, and recognized $74,000 of restricted-stock compensation. For a company with only $623,000 of quarterly revenue, stock compensation and new issuance are not peripheral details; they influence per-share value and insider alignment.
What risks could change Oxbridge Re’s outlook?
The largest risk is catastrophe concentration. A single hurricane can produce a full-limit claim, and the company’s limited treaty count means one event can dominate annual results. The second risk is operating leverage in the wrong direction: legal, audit, investor-relations, compensation and tokenization costs are large relative to earned premiums. The company’s annual risk factors emphasize catastrophe exposure, limited operating history, dependence on key relationships and the uncertainty surrounding digital-asset activities.
What is the key strategic trade-off?
Tokenization may allow Oxbridge to expand underwriting capacity with less permanent common equity, but building that platform requires legal, marketing, technology and compliance spending before recurring fee revenue is proven. FY2025 general and administrative expenses were $3.046 million, up from $1.917 million in FY2024, while SurancePlus fee income fell to $1,000. That mismatch is the clearest near-term risk to the strategy.
Why does Oxbridge Re matter for valuation?
A conventional earnings multiple is a weak primary tool for Oxbridge because catastrophe results, investment fair-value changes, tokenholder allocations and equity issuance can make annual net income highly unstable. A better framework separates three layers: the value of underwriting capital and book equity, the normalized economics of the reinsurance franchise, and the option value of SurancePlus.
| Valuation driver | Current evidence | DCF or book-value implication |
|---|---|---|
| Premium scale | $2.287M net premiums earned in FY2025 | More premium is valuable only if underwriting discipline and expense absorption improve. |
| Normalized combined ratio | 94.3% in FY2024; 264.1% in FY2025; 105.0% in Q1 2026 | Terminal margins are highly sensitive to catastrophe assumptions and fixed costs. |
| Book equity | $6.095M at March 31, 2026 | Book value offers a reference point, but restricted assets and future losses affect realizable value. |
| Token platform | Multiple product series, but minimal FY2025 fee income | Treat as an option with high execution risk rather than established recurring cash flow. |
| Dilution | 8.101M shares outstanding by May 11, 2026 | Enterprise progress must be translated into per-share value after issuance and compensation. |
Which assumptions dominate a DCF?
The most important assumptions are not a smooth revenue growth rate. They are the sustainable combined ratio across a full catastrophe cycle, the amount of unrestricted capital needed to support operations, the proportion of underwriting risk funded by third parties, recurring tokenization fees, and the future share count. Small changes in any of these inputs can materially alter value because the current operating base is small.
What should students and investors monitor next?
Oxbridge should be followed through a compact set of operating and capital signals rather than headline revenue alone. The company’s official SEC filings page, corporate website and future earnings releases provide the best primary-source trail.
What is the key takeaway from Oxbridge Re analysis?
Oxbridge Re is important as a case study in how a micro-cap insurer can combine regulated underwriting, sidecar financing and tokenized real-world assets. The model’s attraction is clear: outside investors can supply collateral and share catastrophe risk, potentially allowing the company to write more business without funding every dollar from ordinary shareholders.
The weakness is equally clear. Premium scale remains small, public-company and Web3 costs are high, catastrophe losses can overwhelm several years of premium, unrestricted liquidity is limited, and common-share issuance has increased the denominator through which value must be measured. Q1 2026’s $22,000 profit was an improvement, but the 105% combined ratio showed that the cost structure still exceeded earned premiums even with a 0% loss ratio.
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.
